Pharmabiz

NPPA allowed discontinuation of 21 scheduled formulations in FY25

NPPA allowed discontinuation of 21 scheduled formulations in FY25: Gireesh Babu, New Delhi Wednesday, October 29, 2025, 08:00 ...
Pharmabiz

Orchestra BioMed enrols first patients in Virtue SAB pivotal investigational device exemption coronary trial

Orchestra BioMed enrols first patients in Virtue SAB pivotal investigational device exemption coronary trial: New Hope, Pennsylvania Wednesday, October 29, 2025, 18:00 Hrs [IST] O ...
Pharmabiz

Ajinomoto Bio-Pharma & Olon S.p.A. form strategic partnership to advance large-scale peptide and protein manufacturing

Ajinomoto Bio-Pharma & Olon S.p.A. form strategic partnership to advance large-scale peptide and protein manufacturing: Tokyo, Japan Wednesday, October 29, 2025, 17:00 Hrs [IST] A ...
Pharmabiz

EMA grants Orphan Drug Designation to GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227 to treat pulmonary neuroendocrine carcinoma

EMA grants Orphan Drug Designation to GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227 to treat pulmonary neuroendocrine carcinoma: London, UK Wednesday, October 29, 2025 ...
Pharmabiz

Metropolis Healthcare study reveals 46% of tested individuals show vitamin D deficiency across India

Metropolis Healthcare study reveals 46% of tested individuals show vitamin D deficiency across India: Our Bureau, Bengaluru Wednesday, October 29, 2025, 14:30 Hrs [IST] Metropolis ...
Pharmabiz

Ramaiah Memorial Hospital underscores need for bone health & osteoporosis diagnosis through advanced DXA scanner

Ramaiah Memorial Hospital underscores need for bone health & osteoporosis diagnosis through advanced DXA scanner: Our Bureau, Bengaluru Wednesday, October 29, 2025, 14:45 Hrs [IST ...
Pharmabiz

Salesforce India debuts Agentforce Life Sciences to drive customer engagement and alleviate doctor burnout

Salesforce India debuts Agentforce Life Sciences to drive customer engagement and alleviate doctor burnout: Our Bureau, Bengaluru Wednesday, October 29, 2025, 16:30 Hrs [IST] Sale ...
Pharmabiz

First UK patient with multiple sclerosis treated with CAR T cell therapy

First UK patient with multiple sclerosis treated with CAR T cell therapy: United Kingdom Wednesday, October 29, 2025, 15:00 Hrs [IST] A patient with multiple sclerosis has become ...
Pharmabiz

SMT’s Supraflex Cruz shows consistent and robust clinical outcomes

SMT’s Supraflex Cruz shows consistent and robust clinical outcomes: Our Bureau, Mumbai Wednesday, October 29, 2025, 16:15 Hrs [IST] Sahajanand Medical Technologies (SMT), a medi ...
Pharmabiz

Merck & Eisai announce Welireg plus Lenvima meets primary endpoint of PFS in certain previously treated patients with advanced RCC

Merck & Eisai announce Welireg plus Lenvima meets primary endpoint of PFS in certain previously treated patients with advanced RCC: Rahway, New Jersey Wednesday, October 29, 2025, ...
Pharmabiz

Roche’s phase III INShore study of Gazyva/Gazyvaro in children and young adults with idiopathic nephrotic syndrome meets its primary endpoints

Roche’s phase III INShore study of Gazyva/Gazyvaro in children and young adults with idiopathic nephrotic syndrome meets its primary endpoints: Basel Wednesday, October 29, 2025 ...
Pharmabiz

Alembic Pharmaceuticals receives US FDA final approval for ticagrelor tablets, 60 mg

Alembic Pharmaceuticals receives US FDA final approval for ticagrelor tablets, 60 mg: Our Bureau, Bengaluru Wednesday, October 29, 2025, 14:15 Hrs [IST] Alembic Pharmaceuticals Li ...